Tech Company Financing Transactions
Boreal Genomics Funding Round
Boreal Genomics, operating out of Vancouver BC, secured $18 million from Arch Venture Partners, Kearny Venture Partners and private investors.
Transaction Overview
Company Name
Announced On
10/7/2013
Transaction Type
Venture Equity
Amount
$18,000,000
Round
Series C
Proceeds Purpose
The financing will be used to expand commercial operations in the translational research market, scale laboratory capabilities and launch clinical applications for non-invasive genomic profiling and monitoring of cancer.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2386 East Mall
Vancouver BC, V6T 1Z3
Canada
Vancouver BC, V6T 1Z3
Canada
Phone
Website
Email Address
Overview
Boreal has developed a revolutionary new approach for analysis of circulating tumor DNA in plasma enabling real-time monitoring of disease progression.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Scientific Officer
Andre Marziali
Chief Technical Officer
Joel Pel
VP - Bus. Development
David Broemeling
VP - Product Management
Matthew Wiggin
Browse more venture capital transactions:
Prev: 10/7/2013: XLumena venture capital transaction
Next: 10/7/2013: FiberLight venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on tech company VC transactions. VC investment data records on this site come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs